Terumo Develops Third-Generation LVAD As Thoratec Builds HeartMate Family
This article was originally published in The Gray Sheet
Executive Summary
New rotary-flow and centrifugal-flow ventricular assist devices are unlikely to ever completely displace pulsatile-flow designs from the LVAD market, Thoratec maintains
You may also be interested in...
MicroMed DeBakey Heart-Assist Device Pivotal Trial Gets IDE Clearance
The pivotal study for MicroMed's DeBakey left-ventricular assist device will be led by Columbia University's Eric Rose, MD, the researcher who helped secure the first FDA approval and Medicare reimbursement of permanent LVADs
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.